Geez... the calendar turned into October and traders are acting like Halloween is already here! The up-and-down trading action so far in the first three days of October can be downright frightening if you're chasing every whipsaw in this schizo tape.
Considering my portfolio is leaning a bit long at the moment, it feels prudent to put some downside exposure on.
The biotech space has been a laggard all year. If broader markets still have additional spook in them, it is likely biotechs will lead the way. So I'm positioning myself accordingly.
You need to have a subscription to access this content in full.
